11/12/2020
A academia Americana de Pediatria acaba de publicar um apelo às indústrias que passem a incluir nos trials (te**es da vacina contra o causador da pandemia de pois nossas crianças e adolescentes não podem continuar às margens dessa proteção vacinal! Muitos malefícios decorrerão dessa exclusão, especialmente aqui em nosso veremos crianças fora das escolas públicas! with
・・・Yesterday, the Vaccine and Related Biological Products Advisory Committee (VRBPAC) issued a recommendation to the in favor of an Emergency Use Authorization for Pfizer-BioNTech's COVID-19 vaccine. While we wait for the FDA to consider the request, the American Academy of Pediatrics recognizes this action as an important step in making a vaccine available but urges continued, robust research on vaccines for children and adolescents.
"Today marks another milestone in the pandemic and brings us one step closer to having a vaccine that will be broadly available to physicians, health care workers, and other front-line medical staff,” said Sally Goza, MD, FAAP, president of the American Academy of Pediatrics. “This is a light at the end of the long tunnel of this pandemic, which has placed heavy burdens on everyone in the medical community, and we look forward to having a vaccine available to protect everyone who has put their own health and safety at risk in order to care for others.”
While the Academy is hopeful that the Pfizer vaccine represents a big step for controlling the virus, the AAP again urges manufacturers to include children in their COVID-19 vaccine trials, including younger children, as soon as it is safe to do so.
Nearly 1.5 million children have been infected with the virus since the beginning of the pandemic, according to data compiled by AAP and the Children’s Hospital Association. Children have suffered in other ways, including disruptions to their education, financial well-being, and mental health. AAP has called for transparency and scientific rigor in research on potential COVID-19 vaccines and renews the call to not leave children out of important vaccine trials.